Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

68Ga-DOTATATE PET for Localization of Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia

NCT03736564 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03736564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03736564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
68Ga-DOTATATE PET for Localization of Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia
Lead sponsor
Mayo Clinic
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2019
Completion date
October 31, 2023
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteomalacia